REGULATORY INTELLIGENCE·Recall
Umary-USA.com Initiates Class I Recall of UNAVY ACIDO HIALURONICO Over Undeclared Potent Drugs
Umary-USA.com initiated a Class I recall of 1,342 bottles of UNAVY ACIDO HIALURONICO due to undeclared Dexamethasone, Diclofenac, and Omeprazole, marketed without FDA approval. This event underscores critical supply chain and regulatory risks for firms distributing dietary supplements or unapproved drugs in the U.S. Businesses must enhance due diligence to avoid severe compliance penalties and reputational damage from tainted products.
90-Day Activity
Umary-USA.comUmary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets
MKMeera Krishnan· Senior Regulatory Intelligence Analyst2025-06-25 Recall